Press release
Investigation announced for Investors in QIAGEN N.V. (NYSE: QGEN) shares
An investigation for investors in QIAGEN N.V. (NYSE: QGEN) shares over potential securities laws violations by QIAGEN N.V.
Investors who purchased shares of QIAGEN N.V. (NYSE: QGEN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by QIAGEN N.V. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Netherlands based QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. QIAGEN N.V. reported that its annual Total Revenue rose from over 1.41 billion in 2017 to over 1.5 billion in 2018 and that its Net Income increased from 40.39 million to 190.38 million in 2018.
Shares of QIAGEN N.V. (NYSE: QGEN) grew from $21.05 per share in June 2016 to $41.47 per share in April 2019.
On October 7, 2019, QIAGEN N.V. announced third quarter results would come in below previous estimates and also announced that its CEO has resigned. QIAGEN N.V. announced it estimates third-quarter sales at constant growth exchange rate of 3%, far lower than its previously estimated sales growth of 4% to 5%. Qiagen also announced its long-term CEO, Peer M. Schatz, who served the Company for 27-years, would resign as CEO and Chairman of the Board effective immediately. The Company's Senior Vice President, Thierry Bernard will act as interim CEO while the Company undertakes a search for a new CEO.
Shares of QIAGEN N.V. (NYSE: QGEN) declined to $25.04 per share on October 9, 2019.
Those who purchased shares of QIAGEN N.V. (NYSE: QGEN) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in QIAGEN N.V. (NYSE: QGEN) shares here
News-ID: 1849755 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for QIAGEN
Microarray Biochips Market is Booming Worldwide |Illumina,Qiagen,Eppendorf
HTF MI just released the Global Microarray Biochips Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Microarray Biochips Market are: Thermo Fisher Scientific,…
Dna Microarray Scanners Market Overall Study Report 2024-2032 | BioRad Laborator …
The Dna Microarray Scanners Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. It's like a compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its future. This report becomes a strategic ally for companies, stakeholders, and industry players, offering…
Bioinformatics Market: Know Opportunity Ahead | Illumina, QIAGEN, Wuxi NextCODE
The latest study released on the Global Bioinformatics Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Bioinformatics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This…
Clinical Oncology Next Generation Sequencing Market Likely To Witness Exponentia …
The global clinical oncology next generation sequencing market size is expected to grow from $0.36 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 9.7%. The global clinical oncology NGS market size is expected to grow to $0.68 billion in 2026 at a CAGR of 14.7%.
The Business Research Company offers the Clinical Oncology Next Generation Sequencing Global Market Report 2022 in its research…
Companion Diagnostics Market Size 2020-26, QIAGEN, Agilent, BioMerieux
The latest study on the Global Companion Diagnostics market report represents a deep appraisal of the international industry. The research report on the worldwide Companion Diagnostics market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Companion Diagnostics industry status and authorized projection related to the Companion Diagnostics market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also…
Biochips Market Share 2020-26, Illumina, PerkinElmer, QIAGEN
The latest study on the Global Biochips market report represents a deep appraisal of the international industry. The research report on the worldwide Biochips market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Biochips industry status and authorized projection related to the Biochips market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also offers an in-depth overview…
